Category: Trikafta

Landmark Deal Set to Make NHS Patients in England Early Adopters of Life-transforming Treatment

In the coming weeks a license is set to be granted by the European Medicines Agency to allow clinicians to begin prescribing a potentially life changing treatment for Cystic Fibrosis suffers. A combination of three different drugs – Elexacaftor, Tezacaftor and Ivacaftor, form the drug known as Trikafta (brand name). Prescriptions for Trikafta have...

Read more »